Absence of association between vitamin D deficiency and incident metabolic syndrome: Tehran lipid and glucose study

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 4, 2013, Pages 236-242

  Amirbaigloo, Alireza ^a   Hosseinpanah, Farhad ^a   Sarvghadi, Farzaneh ^a   Tohidi, Maryam ^b   Eskandary, Parvin Sarbakhsh ^c   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SEX; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

25-HYDROXYVITAMIN D 2; ADULT; BLOOD GLUCOSE; CALCIFEDIOL; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 84880408815     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0121     Document Type: Article

References (38)

1. Azizi F, Salehi P, Etemadi A, et al. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003, 61:29-37.
2. Hadaegh F, Zabetian A, Khalili D, et al. A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community Health 2012;66: 427-432.
3. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-1230.
4. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471-478.
5. Moradzadeh K, Larijani B, Keshtkar AA, et al. Normative values of vitamin D among Iranian population: A population based study. Int J Osteoporosis Metabol Disord 2008;1: 8-15.
6. Stumpf WE, Sar M, Reid FA, et al. Target cells for 1,25- dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979;206:1188-1190.
7. Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25- dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80:1717S-1720S.
8. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238.
9. Sigmund CD. Regulation of renin expression and blood pressure by vitamin D(3). J Clin Invest 2002;110:155-156.
10. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825.
11. Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2001;2:2.
12. Rebsamen MC, Sun J, Norman AW, et al. 1 Alpha, 25- dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 2002;91:17-24.
13. Carthy EP, Yamashita W, Hsu A, et al. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 1989;13:954-959.
14. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and metaanalysis. Maturitas 2010;65:225-236.
15. Forouhi NG, Luan J, Cooper A, et al. Baseline serum 25- hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-2625.
16. Gagnon C, Lu ZX, Magliano DJ, et al. Low serum 25- hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: Results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012;97:1953-1961.
17. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009;10:5.
18. Azizi F, Khalili D, Aghajani H, et al. Appropriate waist circumference cut-off points among Iranian adults: The first report of the Iranian National Committee of Obesity. Arch Iran Med 2010;13:243-244.
19. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
20. Azizi F, Hadaegh F, Khalili D, et al. Appropriate definition of metabolic syndrome among Iranian adults: Report of the Iranian National Committee of Obesity. Arch Iran Med 2010;13:426-428.
21. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930.
22. Heidari Z, Hosseinpanah F, Mehrabi Y, et al. Predictive power of the components of metabolic syndrome in its development: A 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS). Eur J Clin Nutr 2010;64:1207-1214.
23. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-1069.
24. Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19:666-671.
25. Bonakdaran S, Varasteh AR. Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J 2009;30:509-514.
26. Hjelmesaeth J, Hofso D, Aasheim ET, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: A crosssectional study. Cardiovasc Diabetol 2009;8:7.
27. Khader YS, Batieha A, Jaddou H, et al. Relationship between 25-hydroxyvitamin D and metabolic syndrome among Jordanian adults. Nutr Res Pract 2011;5:132-139.
28. Reis JP, von Muhlen D, Kritz-Silverstein D, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007;30:1549-1555.
29. Rueda S, Fernandez-Fernandez C, Romero F, et al. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008;18:151-154.
30. Salekzamani S, Neyestani TR, Alavi-Majd H, et al. Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes Metab Syndr Obes 2011;4:205- 212.
31. Hossein-Nezhad A, Khoshniat Nikoo M, Maghbooli Z, et al. Relationship between serum Vitamin D concentration and Metabolic Syndrome among Iranian Adults Population. DARU 2009;17:1-5.
32. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-314.
33. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: Physiology and biomarkers. Am J Clin Nutr 2008;88:500S-506S.
34. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338: 777-783.
35. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:1931-1942.
36. Hosseinpanah F, Barzin M, Mirmiran P, et al. Effect of changes in waist circumference on metabolic syndrome over a 6.6-year follow-up in Tehran. Eur J Clin Nutr 2010;64:879- 886.
37. Antoniucci DM, Black DM, Sellmeyer DE. Serum 25- hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. Clin Chem 2005;51:258-261.
38. Lissner D, Mason RS, Posen S. Stability of vitamin D metabolites in human blood serum and plasma. Clin Chem 1981;27:773-774.